Mouse monoclonal Antibody Production Service
Alpha Lifetech Inc. has the ability to provide comprehensive services for scientists worldwide regarding mice hybridoma. These services include antigen design/synthesis, immunization, cell fusion, and hybridoma selection/characterization, and we can specialize in each project.
Mouse Mab Production Service- Hybridoma Technology
Antigen Preparation
● Peptide design & synthesis: peptide design, peptide synthesis, conjugation.
● Small molecule design & conjugation: Small molecule modification, conjugation.
● Protein preparation: cDNA synthesis, vector construction, protein expression & purification.
● Virus particles (Inactivated or attenuated).
Quality Control
Protein A/G purification
Antigen-specific affinity purification
Immunization
Immunized 4-5 mice (Complete Freund's adjuvant (CFA) and incomplete Freund's adjuvant (IFA) were injected subcutaneously on days 14, 21, 38, 52, and 68.)
Serum ELISA detection
ELISA titer>10^5 (Protein antigen, virus particles), ELISA titer>10^4 (Peptides or other molecules)
Fusion & Screening
Myeloma cells fused with splenocytes. The fusion of the B cells with myeloma cells can be done using electrofusion or PEG. Fused cells (B cells fused with myeloma cells) are incubated in HAT medium (hypoxanthine-aminopterin-thymidine medium) for roughly 2 weeks, since they have the hypoxanthine-guanine phosphoribosyltransferase (HGPRT) gene, making them non-sensitive and alive to the HAT medium. Screening is a rapid primary screening process, which identifies and selects only those hybridomas that produce antibodies of appropriate specificity.
Antibody validation
Our experienced team provides high-throughput hybridoma screening by ELISA, FACS, and other image-based binding methodologies (e.g., microbeads), as well as antibody biochemical characterization to ensure the identification of hybridoma candidates with high potency and to meet the special requirements of functional assays and animal studies.
Antibody production
Large-scale production of mouse monoclonal antibodies.